1,529
Views
63
CrossRef citations to date
0
Altmetric
Special Focus Review

CD117+ amniotic fluid stem cells

State of the art and future perspectives

&
Pages 77-88 | Published online: 01 Jul 2012

References

  • Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol 2005; 25:341 - 8; http://dx.doi.org/10.1038/sj.jp.7211290; PMID: 15861199
  • Klemmt PA, Vafaizadeh V, Groner B. The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expert Opin Biol Ther 2011; 11:1297 - 314; http://dx.doi.org/10.1517/14712598.2011.587800; PMID: 21623704
  • Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev 2006; 2:133 - 42; http://dx.doi.org/10.1007/s12015-006-0020-0; PMID: 17237552
  • Mescher EJ, Platzker AC, Ballard PL, Kitterman JA, Clements JA, Tooley WH. Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb. J Appl Physiol 1975; 39:1017 - 21; PMID: 2573
  • Le Moyec L, Muller F, Eugene M, Spraul M. Proton magnetic resonance spectroscopy of human amniotic fluids sampled at 17-18 weeks of pregnancy in cases of decreased digestive enzyme activities and detected cystic fibrosis. Clin Biochem 1994; 27:475 - 83; http://dx.doi.org/10.1016/0009-9120(94)00051-V; PMID: 7697893
  • Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 2004; 18:877 - 91; http://dx.doi.org/10.1016/j.bpobgyn.2004.07.001; PMID: 15582544
  • Dobreva MP, Pereira PN, Deprest J, Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 2010; 54:761 - 77; http://dx.doi.org/10.1387/ijdb.092935md; PMID: 20446274
  • Lotgering FK, Wallenburg HC. Mechanisms of production and clearance of amniotic fluid. Semin Perinatol 1986; 10:94 - 102; PMID: 3541226
  • Gosden CM. Amniotic fluid cell types and culture. Br Med Bull 1983; 39:348 - 54; PMID: 6357346
  • Cremer M, Schachner M, Cremer T, Schmidt W, Voigtländer T. Demonstration of astrocytes in cultured amniotic fluid cells of three cases with neural-tube defect. Hum Genet 1981; 56:365 - 70; http://dx.doi.org/10.1007/BF00274694; PMID: 7016720
  • Cremer M, Treiss I, Cremer T, Hager D, Franke WW. Characterization of cells of amniotic fluids by immunological identification of intermediate-sized filaments: presence of cells of different tissue origin. Hum Genet 1981; 59:373 - 9; http://dx.doi.org/10.1007/BF00295475; PMID: 6174407
  • Johnston P, Salk D, Martin GM, Hoehn H. Cultivated cells from mid-trimester amniotic fluids: IV. Cell type indentification via one and two-dimensional electrophoresis of clonal whole cell homogenates. Prenat Diagn 1982; 2:79 - 88; http://dx.doi.org/10.1002/pd.1970020202; PMID: 7145843
  • Milunsky A, Blusztajn JK, Zeisel SH. Amniotic-fluid total cholinesterase and neural-tube defects. Lancet 1979; 2:36; http://dx.doi.org/10.1016/S0140-6736(79)90196-X; PMID: 87905
  • Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 2009; 18:Suppl 1 17 - 27; http://dx.doi.org/10.1016/S1472-6483(10)60111-3; PMID: 19281660
  • Hoehn H, Bryant EM, Fantel AG, Martin GM. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. III. The fetal urine as a potential source of clonable cells. Humangenetik 1975; 29:285 - 90; http://dx.doi.org/10.1007/BF00394190; PMID: 1176144
  • Gosden C, Brock DJ. Amniotic fluid cell morphology in early antenatal prediction of abortion and low birth weight. Br Med J 1978; 2:1186 - 9; http://dx.doi.org/10.1136/bmj.2.6146.1186; PMID: 82463
  • Siegel N, Rosner M, Hanneder M, Valli A, Hengstschläger M. Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev 2007; 3:256 - 64; http://dx.doi.org/10.1007/s12015-007-9003-z; PMID: 17955390
  • Torricelli F, Brizzi L, Bernabei PA, Gheri G, Di Lollo S, Nutini L, et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol 1993; 98:119 - 26; PMID: 8239855
  • Streubel B, Martucci-Ivessa G, Fleck T, Bittner RE. In vitro transformation of amniotic cells to muscle cells–background and outlook. Wien Med Wochenschr 1996; 146:216 - 7; PMID: 9012220
  • Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod 2003; 18:1489 - 93; http://dx.doi.org/10.1093/humrep/deg279; PMID: 12832377
  • Schöler HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 1989; 8:2543 - 50; PMID: 2573523
  • Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24:372 - 6; http://dx.doi.org/10.1038/74199; PMID: 10742100
  • Donovan PJ, De Miguel MP, Hirano MP, Parsons MS, Lincoln AJ. Germ cell biology–from generation to generation. Int J Dev Biol 2001; 45:523 - 31; PMID: 11417895
  • Pesce M, Schöler HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001; 19:271 - 8; http://dx.doi.org/10.1634/stemcells.19-4-271; PMID: 11463946
  • Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003; 4:361 - 70; http://dx.doi.org/10.1016/S1535-6108(03)00270-8; PMID: 14667503
  • Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63:2244 - 50; PMID: 12727846
  • Berg JS, Goodell MA. An argument against a role for Oct4 in somatic stem cells. Cell Stem Cell 2007; 1:359 - 60; http://dx.doi.org/10.1016/j.stem.2007.09.007; PMID: 18371372
  • Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S, et al. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007; 1:403 - 15; http://dx.doi.org/10.1016/j.stem.2007.07.020; PMID: 18159219
  • Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kögler G. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 2007; 1:364 - 6; http://dx.doi.org/10.1016/j.stem.2007.09.003; PMID: 18371374
  • Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 2006; 16:329 - 36; http://dx.doi.org/10.1038/sj.cr.7310043; PMID: 16617328
  • Stefanidis K, Loutradis D, Anastasiadou V, Bletsa R, Kiapekou E, Drakakis P, et al. Oxytocin receptor- and Oct-4-expressing cells in human amniotic fluid. Gynecol Endocrinol 2008; 24:280 - 4; http://dx.doi.org/10.1080/09513590801977167; PMID: 18569033
  • Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G, Hengstschläger M. Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med 2005; 16:987 - 92; PMID: 16273276
  • Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74:545 - 51; http://dx.doi.org/10.1095/biolreprod.105.046029; PMID: 16306422
  • Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40:75 - 90; http://dx.doi.org/10.1111/j.1365-2184.2007.00414.x; PMID: 17227297
  • De Coppi P, Bartsch G Jr., Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100 - 6; http://dx.doi.org/10.1038/nbt1274; PMID: 17206138
  • Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63:213 - 24; http://dx.doi.org/10.1016/0092-8674(90)90302-U; PMID: 1698556
  • Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, et al. Human and murine amniotic fluid c-Kit+Lin- cells display hematopoietic activity. Blood 2009; 113:3953 - 60; http://dx.doi.org/10.1182/blood-2008-10-182105; PMID: 19221036
  • Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, et al. Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach. Mol Ther 2012; 20:1953 - 67; http://dx.doi.org/10.1038/mt.2012.117; PMID: 22760542
  • Sedrakyan S, Da Sacco S, Milanesi A, Shiri L, Petrosyan A, Varimezova R, et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol 2012; 23:661 - 73; http://dx.doi.org/10.1681/ASN.2011030243; PMID: 22302195
  • Bollini S, Pozzobon M, Nobles M, Riegler J, Dong X, Piccoli M, et al. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev 2011; 7:364 - 80; http://dx.doi.org/10.1007/s12015-010-9200-z; PMID: 21120638
  • Arnhold S, Glüer S, Hartmann K, Raabe O, Addicks K, Wenisch S, et al. Amniotic-Fluid Stem Cells: Growth Dynamics and Differentiation Potential after a CD-117-Based Selection Procedure. Stem Cells Int 2011; 2011:715341; http://dx.doi.org/10.4061/2011/715341; PMID: 21437196
  • Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, Habibian R, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007; 40:936 - 48; http://dx.doi.org/10.1111/j.1365-2184.2007.00478.x; PMID: 18021180
  • Valli A, Rosner M, Fuchs C, Siegel N, Bishop CE, Dolznig H, et al. Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene 2010; 29:966 - 77; http://dx.doi.org/10.1038/onc.2009.405; PMID: 19935716
  • Piccoli M, Franzin C, Bertin E, Urbani L, Blaauw B, Repele A, et al. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model. Stem Cells 2012; 30:1675 - 84; http://dx.doi.org/10.1002/stem.1134; PMID: 22644669
  • Siegel N, Rosner M, Unbekandt M, Fuchs C, Slabina N, Dolznig H, et al. Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet 2010; 19:3320 - 31; http://dx.doi.org/10.1093/hmg/ddq236; PMID: 20542987
  • Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008; 26:2902 - 11; http://dx.doi.org/10.1634/stemcells.2008-0090; PMID: 18719226
  • Chiavegato A, Bollini S, Pozzobon M, Callegari A, Gasparotto L, Taiani J, et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol 2007; 42:746 - 59; http://dx.doi.org/10.1016/j.yjmcc.2006.12.008; PMID: 17300799
  • Gekas J, Walther G, Skuk D, Bujold E, Harvey I, Bertrand OF. In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage. Clin Exp Med 2010; 10:1 - 6; http://dx.doi.org/10.1007/s10238-009-0060-2; PMID: 19730985
  • Ma X, Zhang S, Zhou J, Chen B, Shang Y, Gao T, et al. Clone-derived human AF-amniotic fluid stem cells are capable of skeletal myogenic differentiation in vitro and in vivo. J Tissue Eng Regen Med 2012; 6:598 - 613; http://dx.doi.org/10.1002/term.462; PMID: 22396316
  • Guan X, Delo DM, Atala A, Soker S. In vitro cardiomyogenic potential of human amniotic fluid stem cells. J Tissue Eng Regen Med 2011; 5:220 - 8; http://dx.doi.org/10.1002/term.308; PMID: 20687122
  • Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, Atala A, et al. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 2012; 21:1911 - 23; http://dx.doi.org/10.1089/scd.2011.0333; PMID: 22066606
  • Chen WQ, Siegel N, Li L, Pollak A, Hengstschläger M, Lubec G. Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25. J Proteome Res 2009; 8:5285 - 95; http://dx.doi.org/10.1021/pr900630s; PMID: 19791749
  • Solter D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat Rev Genet 2006; 7:319 - 27; http://dx.doi.org/10.1038/nrg1827; PMID: 16534514
  • Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000; 6:88 - 95; PMID: 10859025
  • Fuchs C, Rosner M, Dolznig H, Mikula M, Kramer N, Hengstschläger M. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation. Hum Mol Genet 2012; 21:1049 - 61; http://dx.doi.org/10.1093/hmg/ddr535; PMID: 22090422
  • Siegel N, Valli A, Fuchs C, Rosner M, Hengstschläger M. Expression of mTOR pathway proteins in human amniotic fluid stem cells. Int J Mol Med 2009; 23:779 - 84; PMID: 19424604
  • Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, Shiri L, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 2010; 5:e9357; http://dx.doi.org/10.1371/journal.pone.0009357; PMID: 20195358
  • Yao M, Dieterle T, Hale SL, Dow JS, Kedes LH, Peterson KL, et al. Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol 2003; 35:661 - 70; http://dx.doi.org/10.1016/S0022-2828(03)00098-1; PMID: 12788384
  • Dai W, Kloner RA. Myocardial regeneration by human amniotic fluid stem cells: challenges to be overcome. J Mol Cell Cardiol 2007; 42:730 - 2; http://dx.doi.org/10.1016/j.yjmcc.2007.01.013; PMID: 17362984
  • Delo DM, Guan X, Wang Z, Groban L, Callahan M, Smith T, et al. Calcification after myocardial infarction is independent of amniotic fluid stem cell injection. Cardiovasc Pathol 2011; 20:e69 - 78; http://dx.doi.org/10.1016/j.carpath.2010.03.001; PMID: 20382039
  • Bollini S, Cheung KK, Riegler J, Dong X, Smart N, Ghionzoli M, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 2011; 20:1985 - 94; http://dx.doi.org/10.1089/scd.2010.0424; PMID: 21534857
  • Price FD, Kuroda K, Rudnicki MA. Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 2007; 1772:272 - 83; http://dx.doi.org/10.1016/j.bbadis.2006.08.011; PMID: 17034994
  • Meregalli M, Farini A, Colleoni F, Cassinelli L, Torrente Y. The role of stem cells in muscular dystrophies. Curr Gene Ther 2012; 12:192 - 205; http://dx.doi.org/10.2174/156652312800840559; PMID: 22463740
  • Beardi J, Hessmann M, Hansen M, Rommens PM. Operative treatment of tibial shaft fractures: a comparison of different methods of primary stabilisation. Arch Orthop Trauma Surg 2008; 128:709 - 15; http://dx.doi.org/10.1007/s00402-008-0619-5; PMID: 18465138
  • Salgado AJ, Oliveira JT, Pedro AJ, Reis RL. Adult stem cells in bone and cartilage tissue engineering. Curr Stem Cell Res Ther 2006; 1:345 - 64; PMID: 18220879
  • Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001; 414:118 - 21; http://dx.doi.org/10.1038/35102181; PMID: 11689957
  • Peister A, Deutsch ER, Kolambkar Y, Hutmacher DW, Guldberg RE. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A 2009; 15:3129 - 38; http://dx.doi.org/10.1089/ten.tea.2008.0536; PMID: 19344289
  • Maraldi T, Riccio M, Resca E, Pisciotta A, La Sala GB, Ferrari A, et al. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Tissue Eng Part A 2011; 17:2833 - 43; http://dx.doi.org/10.1089/ten.tea.2011.0062; PMID: 21864161
  • Peister A, Woodruff MA, Prince JJ, Gray DP, Hutmacher DW, Guldberg RE. Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Res 2011; 7:17 - 27; http://dx.doi.org/10.1016/j.scr.2011.03.001; PMID: 21531647
  • Sun H, Feng K, Hu J, Soker S, Atala A, Ma PX. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 2010; 31:1133 - 9; http://dx.doi.org/10.1016/j.biomaterials.2009.10.030; PMID: 19857889
  • Rodrigues MT, Lee BK, Lee SJ, Gomes ME, Reis RL, Atala A, et al. The effect of differentiation stage of amniotic fluid stem cells on bone regeneration. Biomaterials 2012; 33:6069 - 78; http://dx.doi.org/10.1016/j.biomaterials.2012.05.016; PMID: 22672834
  • Riccio M, Maraldi T, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, et al. Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells. Tissue Eng Part A 2012; 18:1006 - 13; http://dx.doi.org/10.1089/ten.tea.2011.0542; PMID: 22166080
  • Koelling S, Miosge N. Stem cell therapy for cartilage regeneration in osteoarthritis. Expert Opin Biol Ther 2009; 9:1399 - 405; http://dx.doi.org/10.1517/14712590903246370; PMID: 19793003
  • Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 2007; 38:405 - 13; http://dx.doi.org/10.1007/s10735-007-9118-1; PMID: 17668282
  • Bussolati B, Hauser PV, Carvalhosa R, Camussi G. Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther 2009; 4:2 - 8; http://dx.doi.org/10.2174/157488809787169129; PMID: 19149624
  • Bruce SJ, Rea RW, Steptoe AL, Busslinger M, Bertram JF, Perkins AC. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation 2007; 75:337 - 49; http://dx.doi.org/10.1111/j.1432-0436.2006.00149.x; PMID: 17286599
  • Bruno S, Bussolati B, Grange C, Collino F, di Cantogno LV, Herrera MB, et al. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev 2009; 18:867 - 80; http://dx.doi.org/10.1089/scd.2008.0320; PMID: 19579288
  • Fuente Mora C, Ranghini E, Bruno S, Bussolati B, Camussi G, Wilm B, et al. Differentiation of podocyte and proximal tubule-like cells from a mouse kidney-derived stem cell line. Stem Cells Dev 2012; 21:296 - 307; http://dx.doi.org/10.1089/scd.2010.0470; PMID: 21510739
  • Kramer J, Steinhoff J, Klinger M, Fricke L, Rohwedel J. Cells differentiated from mouse embryonic stem cells via embryoid bodies express renal marker molecules. Differentiation 2006; 74:91 - 104; http://dx.doi.org/10.1111/j.1432-0436.2006.00062.x; PMID: 16533308
  • Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26:2075 - 82; http://dx.doi.org/10.1634/stemcells.2007-0795; PMID: 18499895
  • Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010; 28:513 - 22; PMID: 20049901
  • Murray P, Camussi G, Davies JA, Edgar D, Hengstschlager M, Kenny S, et al. The KIDSTEM European Research Training Network: Developing a Stem Cell Based Therapy to Replace Nephrons Lost through Reflux Nephropathy. Organogenesis 2007; 3:2 - 5; http://dx.doi.org/10.4161/org.3.1.3440; PMID: 19279693
  • Hauser PV, De Fazio R, Bruno S, Sdei S, Grange C, Bussolati B, et al. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 2010; 177:2011 - 21; http://dx.doi.org/10.2353/ajpath.2010.091245; PMID: 20724594
  • Rosner M, Schipany K, Gundacker C, Shanmugasundaram B, Li K, Fuchs C, et al. Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases. Eur J Clin Invest 2012; 42:677 - 84; http://dx.doi.org/10.1111/j.1365-2362.2011.02622.x; PMID: 22060053
  • Loebinger MR, Aguilar S, Janes SM. Therapeutic potential of stem cells in lung disease: progress and pitfalls. Clin Sci (Lond) 2008; 114:99 - 108; http://dx.doi.org/10.1042/CS20070073; PMID: 18062775
  • Moodley Y, Manuelpillai U, Weiss DJ. Cellular therapies for lung disease: a distant horizon. Respirology 2011; 16:223 - 37; http://dx.doi.org/10.1111/j.1440-1843.2010.01914.x; PMID: 21199158
  • Buckley S, Shi W, Carraro G, Sedrakyan S, Da Sacco S, Driscoll BA, et al. The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors. Am J Respir Cell Mol Biol 2011; 45:1212 - 21; http://dx.doi.org/10.1165/rcmb.2010-0325OC; PMID: 21700959
  • Carney BJ, Shah K. Migration and fate of therapeutic stem cells in different brain disease models. Neuroscience 2011; 197:37 - 47; http://dx.doi.org/10.1016/j.neuroscience.2011.08.063; PMID: 21946010
  • Decimo I, Bifari F, Krampera M, Fumagalli G. Neural stem cell niches in health and diseases. Curr Pharm Des 2012; 18:1755 - 83; http://dx.doi.org/10.2174/138161212799859611; PMID: 22394166
  • Rosner M, Schipany K, Shanmugasundaram B, Lubec G, Hengstschläger M. Amniotic fluid stem cells: future perspectives. Stem Cells Int 2012; 2012:741810; http://dx.doi.org/10.1155/2012/741810; PMID: 22719774
  • Toselli M, Cerbai E, Rossi F, Cattaneo E. Do amniotic fluid-derived stem cells differentiate into neurons in vitro?. Nat Biotechnol 2008; 26:269 - 70, author reply 270-1; http://dx.doi.org/10.1038/nbt0308-269; PMID: 18327228
  • Da Sacco S, De Filippo RE, Perin L. Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration. Curr Opin Organ Transplant 2010; In press PMID: 21157345
  • Da Sacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto P, Habibian R, et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 2010; 183:1193 - 200; http://dx.doi.org/10.1016/j.juro.2009.11.006; PMID: 20096867
  • Jiang TM, Yang ZJ, Kong CZ, Zhang HT. Schwann-like cells can be induction from human nestin-positive amniotic fluid mesenchymal stem cells. In Vitro Cell Dev Biol Anim 2010; 46:793 - 800; http://dx.doi.org/10.1007/s11626-010-9335-x; PMID: 20652439
  • Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007; 116:Suppl I64 - 70; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.681494; PMID: 17846327
  • Bajada S, Mazakova I, Richardson JB, Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008; 2:169 - 83; http://dx.doi.org/10.1002/term.83; PMID: 18493906
  • Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108:612 - 6; http://dx.doi.org/10.1097/01.AOG.0000232512.46869.fc; PMID: 16946222
  • Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006; 108:1067 - 72; http://dx.doi.org/10.1097/01.AOG.0000240135.13594.07; PMID: 17077226
  • Daley GQ, Ahrlund Richter L, Auerbach JM, Benvenisty N, Charo RA, Chen G, et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 2007; 315:603 - 4; http://dx.doi.org/10.1126/science.1139337; PMID: 17272706
  • Edwards RG. A burgeoning science of embryological genetics demands a modern ethics. Reprod Biomed Online 2007; 15:Suppl 1 34 - 40; http://dx.doi.org/10.1016/S1472-6483(10)60356-2; PMID: 17822615
  • Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007; 11:981 - 1011; http://dx.doi.org/10.1111/j.1582-4934.2007.00088.x; PMID: 17979879
  • Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8:106 - 18; http://dx.doi.org/10.1016/j.stem.2010.12.003; PMID: 21211785
  • Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458:771 - 5; http://dx.doi.org/10.1038/nature07864; PMID: 19252477
  • Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4:472 - 6; http://dx.doi.org/10.1016/j.stem.2009.05.005; PMID: 19481515
  • Mukherjee S, Thrasher AJ. iPSCs: Unstable origins?. Mol Ther 2011; 19:1188 - 90; http://dx.doi.org/10.1038/mt.2011.116; PMID: 21720379
  • Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 2011; 6:78 - 88; http://dx.doi.org/10.1038/nprot.2010.173; PMID: 21212777
  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663 - 76; http://dx.doi.org/10.1016/j.cell.2006.07.024; PMID: 16904174
  • Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7:618 - 30; http://dx.doi.org/10.1016/j.stem.2010.08.012; PMID: 20888316
  • Ghionzoli M, Cananzi M, Zani A, Rossi CA, Leon FF, Pierro A, et al. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int 2010; 26:79 - 84; http://dx.doi.org/10.1007/s00383-009-2504-x; PMID: 19855985
  • Kunisaki SM, Armant M, Kao GS, Stevenson K, Kim H, Fauza DO. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 2007; 42:974 - 9, discussion 979-80; http://dx.doi.org/10.1016/j.jpedsurg.2007.01.031; PMID: 17560205
  • Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005; 366:2019 - 25; http://dx.doi.org/10.1016/S0140-6736(05)67813-0; PMID: 16338451

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.